Remix Therapeutics reveals unprecedented insights into RNA alternative splicing regulation through RNA sequencing
Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing…
Browsing: Industry News
Parse Launches GigaLab to scale single cell sequencing to billions of cells annually
Demonstrates capabilities with 10 million cells and 1,000+ samples in a single run Parse Biosciences,…
Wobble Genomics’ new tech demonstrates the power of RNA sequencing in identifying rare RNA transcript variants
Wobble Genomics, a healthcare and biotechnology company at the forefront of long-read RNA sequencing, will…
PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program
PacBio, a leading developer of high-quality, highly accurate genomic sequencing solutions, today announced the inclusion…
NeoGenomics Receives New York State Approval for NGS Solid Tumor Test
NeoGenomics, a leading oncology testing services company, today announced that the New York State Department of…
Cytosurge and Lexogen Partner to Advance Live-Cell RNA Sequencing
Cytosurge AG, a leader in single-cell manipulation, and Lexogen, a pioneer in RNA sequencing solutions,…
PacBio enters new collaboration with the National Cancer Centre of Singapore – will emphasize single-cell RNA sequencing
PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced the signing of…
Magnitude.io Announces Collaboration with Purdue University for RNA Sequencing in Upcoming Astrobotany Mission
Purdue University joins the ExoLab-11 mission, studying seeds germinated and grown on the International Space Station.…
TGen Named Certified Service Provider for PacBio
The Translational Genomics Research Institute (TGen), part of City of Hope, announced that it has received…
Foundation Medicine to Provide Tumor Molecular Profiling to Veterans with Cancer
Foundation Medicine was awarded its second consecutive, five-year contract by the U.S. Department of Veterans…